Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: UT59FF4T5X

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor receptor superfamily member 5 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1743005
FDA SRS UT59FF4T5X